Psyence Biomedical (PBMWW) Competitors $0.0077 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends PBMWW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ARAV, ACABW, ACABU, and BFRIWShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera Psyence Biomedical (NASDAQ:PBMWW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Does the MarketBeat Community believe in PBMWW or ATNFW? Psyence Biomedical and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPsyence BiomedicalN/AN/A180 Life SciencesN/AN/A Is PBMWW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor PBMWW or ATNFW? In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Psyence Biomedical Neutral 180 Life Sciences Neutral Which has better valuation and earnings, PBMWW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryPsyence Biomedical and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBMWW vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$6.48B$2.13B$8.87BDividend YieldN/A8.12%2.68%4.06%P/E RatioN/A5.5627.0814.18Price / SalesN/A348.14489.6389.42Price / CashN/A22.1540.2232.79Price / BookN/A7.882.135.12Net IncomeN/A$153.61M$165.18M$225.99M7 Day PerformanceN/A-2.00%0.31%-1.32%1 Month PerformanceN/A-7.47%0.02%0.60%1 Year PerformanceN/A31.80%10.81%26.23% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMWWPsyence BiomedicalN/A$0.01flatN/AN/A$0.00N/A0.00N/AGap UpATNFW180 Life SciencesN/A$0.01flatN/A-25.0%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04-20.6%N/A-71.9%$0.00N/A0.002AIMDWAinosN/A$0.03flatN/AN/A$0.00$40,633.000.0040ALVOWAlvotechN/A$3.10-7.7%N/A+105.3%$0.00$306.77M0.004ALVOAlvotech2.9083 of 5 stars$12.42-0.6%$18.00+44.9%+35.9%$0.00$93.38M0.001,026ARAVAravive0.8318 of 5 stars$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.08flatN/A+77.4%$0.00N/A0.004ACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/A-23.6%$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.05flatN/A+179.9%$0.00$35.24M0.0070 Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Alvotech Alternatives Aravive Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBMWW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.